1. Home
  2. SABS vs DTCK Comparison

SABS vs DTCK Comparison

Compare SABS & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • DTCK
  • Stock Information
  • Founded
  • SABS 2014
  • DTCK 1999
  • Country
  • SABS United States
  • DTCK Singapore
  • Employees
  • SABS N/A
  • DTCK N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • DTCK Farming/Seeds/Milling
  • Sector
  • SABS Health Care
  • DTCK Industrials
  • Exchange
  • SABS Nasdaq
  • DTCK Nasdaq
  • Market Cap
  • SABS 15.8M
  • DTCK 18.3M
  • IPO Year
  • SABS N/A
  • DTCK 2023
  • Fundamental
  • Price
  • SABS $2.35
  • DTCK $0.80
  • Analyst Decision
  • SABS Strong Buy
  • DTCK
  • Analyst Count
  • SABS 4
  • DTCK 0
  • Target Price
  • SABS $9.50
  • DTCK N/A
  • AVG Volume (30 Days)
  • SABS 427.8K
  • DTCK 407.7K
  • Earning Date
  • SABS 11-05-2025
  • DTCK 11-12-2025
  • Dividend Yield
  • SABS N/A
  • DTCK N/A
  • EPS Growth
  • SABS N/A
  • DTCK N/A
  • EPS
  • SABS N/A
  • DTCK N/A
  • Revenue
  • SABS $114,698.00
  • DTCK $132,369,000.00
  • Revenue This Year
  • SABS N/A
  • DTCK N/A
  • Revenue Next Year
  • SABS N/A
  • DTCK N/A
  • P/E Ratio
  • SABS N/A
  • DTCK N/A
  • Revenue Growth
  • SABS N/A
  • DTCK N/A
  • 52 Week Low
  • SABS $1.00
  • DTCK $0.40
  • 52 Week High
  • SABS $6.60
  • DTCK $1.50
  • Technical
  • Relative Strength Index (RSI)
  • SABS 54.67
  • DTCK 43.45
  • Support Level
  • SABS $2.20
  • DTCK $0.72
  • Resistance Level
  • SABS $2.60
  • DTCK $0.77
  • Average True Range (ATR)
  • SABS 0.19
  • DTCK 0.09
  • MACD
  • SABS 0.02
  • DTCK -0.00
  • Stochastic Oscillator
  • SABS 68.00
  • DTCK 17.33

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: